Doses of fluticasone propionate inhalation powder 50 and 100 mcg twice daily significantly improved FEV1 (15% and 18% change from baseline at Endpoint, respectively) compared with placebo (7% change).

Objective: To evaluate the efficacy and tolerability of two inhaled corticosteroid treatment regimens, fluticasone propionate (FP) delivered from a Diskus TM inhaler and budesonide delivered from ...

A total of 332 patients entered the study and 277 patients were randomised and treated, 137 with FP250µg twice daily via Diskus TM inhaler and ... for each treatment [fluticasone propionate ...

The abbreviated new drug application (ANDA) for the fluticasone propionate and salmeterol inhalation powder – named VR 315 – will see Vectura receive $10 million for its part in the drug's ...